Prevalence and Risk Factors for Augmented Renal Clearance in a Population of Critically Ill Patients

被引:32
|
作者
Baptista, Joao Pedro [1 ]
Martins, Paulo Jorge [1 ]
Marques, Margarida [2 ]
Pimentel, Jorge Manuel [1 ]
机构
[1] Ctr Hosp & Univ Coimbra CHUC, Dept Intens Care, Coimbra, Portugal
[2] Ctr Hosp & Univ Coimbra CHUC, Dept Stat, Coimbra, Portugal
关键词
critical care; epidemiology; augmented renal clearance; risk; creatinine clearance; antibiotics; CREATININE CLEARANCE; ICU; HYPERFILTRATION; WEIGHT;
D O I
10.1177/0885066618809688
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Critically ill patients show a high, albeit variable, prevalence of augmented renal clearance (ARC). This condition has relevant consequences on the elimination of hydrophilic drugs. Knowledge of risk factors for ARC helps in the early identification of ARC. The aims of this study were evaluation of (1) risk factors for ARC and (2) the prevalence of ARC in critically ill patients over a period of 1 year. Methods: A retrospective cohort study was performed for all consecutive patients admitted to our intensive care unit (ICU). Augmented renal clearance was defined by a creatinine clearance >= 130 mL/min/1.73 m(2). "Patient with ARC" was defined as a patient with a median of creatinine clearance >= 130 mL/min/1.73 m(2)over the period of admission. Four variables were tested, Simplified Acute Physiology Score II (SAPS II), male gender, age, and trauma as cause for ICU admission. An analysis (patient based and clearance based) was performed with logistic regression. Results: Of 475 patients, 446 were included in this study, contributing to 454 ICU admissions and 5586 8-hour creatinine clearance (8h-CLCR). Overall, the prevalence of patients with ARC was 24.9% (n = 113). In a subset of patients with normal serum creatinine levels, the prevalence was 43.0% (n = 104). Of the set of all 8h-CL(CR)measurements, 25.4% (1418) showed ARC. In the patient-based analysis, the adjusted odds ratio was: 2.0 (confidence interval [CI]:1.1-3.7;P< .05), 0.93 (CI: 0.91-0.94;P< .01), 2.7 (CI: 1.4-5.3;P< .01), and 0.98 (CI: 0.96 -1.01;P= .15), respectively, for trauma, age, male sex, and SAPS II. In the clearance-based analysis, the adjusted odds ratio were 1.7 (CI: 1.4-1.9;P< .01), 0.94 (CI: 0.932-0.942;P< .01), and 2.9 (CI: 2.4-3.4;P< .01), respectively, for trauma, age, and male sex. Conclusions: Trauma, young age, and male sex were independent risk factors for ARC. This condition occurs in a considerable proportion of critical care patients, which was particularly prevalent in patients without evidence of renal dysfunction.
引用
收藏
页码:1044 / 1052
页数:9
相关论文
共 50 条
  • [41] PREDICTABILITY OF CREATININE CLEARANCE ESTIMATES IN CRITICALLY ILL PATIENTS
    ROBERT, S
    ZAROWITZ, BJ
    PETERSON, EL
    DUMLER, F
    CRITICAL CARE MEDICINE, 1993, 21 (10) : 1487 - 1495
  • [42] Population pharmacokinetics of vancomycin in Chinese patients with augmented renal clearance
    Chu, Yang
    Luo, Yifan
    Ji, Shuangmin
    Jiang, Mingyan
    Zhou, Baosen
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (01) : 68 - 74
  • [43] Prevalence and Risk Factors of Augmented Renal Clearance: A Systematic Review and Meta-Analysis
    Hefny, Fatma
    Stuart, Anna
    Kung, Janice Y.
    Mahmoud, Sherif Hanafy
    PHARMACEUTICS, 2022, 14 (02)
  • [44] Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
    Thibaud Besnard
    Cédric Carrié
    Laurent Petit
    Matthieu Biais
    Critical Care, 23
  • [45] Pharmacists' Knowledge About the Impact of Augmented Renal Clearance on Antimicrobial Dosing in Critically Ill Patients: A Cross-Sectional Study
    Almulhim, Abdulaziz S.
    Al-Dahneen, Batool A.
    Alsowaida, Yazed S.
    INFECTIOUS DISEASES AND THERAPY, 2020, 9 (03) : 599 - 608
  • [46] Pharmacists’ Knowledge About the Impact of Augmented Renal Clearance on Antimicrobial Dosing in Critically Ill Patients: A Cross-Sectional Study
    Abdulaziz S. Almulhim
    Batool A. Al-Dahneen
    Yazed S. Alsowaida
    Infectious Diseases and Therapy, 2020, 9 : 599 - 608
  • [47] Augmented renal clearance in septic patients and implications for vancomycin optimisation
    Baptista, Joao Pedro
    Sousa, Eduardo
    Martins, Paulo J.
    Pimentel, Jorge M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2012, 39 (05) : 420 - 423
  • [48] Increased dosing regimens of piperacillin-tazobactam are needed to avoid subtherapeutic exposure in critically ill patients with augmented renal clearance
    Besnard, Thibaud
    Carrie, Cedric
    Petit, Laurent
    Biais, Matthieu
    CRITICAL CARE, 2019, 23 (1):
  • [49] Development and validation of the prediction score for augmented renal clearance in critically Ill Japanese adults
    Mikami, Ryusei
    Imai, Shungo
    Hayakawa, Mineji
    Kashiwagi, Hitoshi
    Sato, Yuki
    Nashimoto, Shunsuke
    Sugawara, Mitsuru
    Takekuma, Yoh
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2024, 10 (01):
  • [50] Augmented Renal Clearance in Patients with Subarachnoid Hemorrhage
    Casey C. May
    Shaily Arora
    Sara E. Parli
    Justin F. Fraser
    Melissa Thompson Bastin
    Aaron M. Cook
    Neurocritical Care, 2015, 23 : 374 - 379